Hot Stocks
Monday, June 6, 2016
Sarepta says FDA asks for more data for its muscle-wasting treatment
June 6 (Reuters) - Sarepta Therapeutics Inc said
the U.S. Food and Drug Administration has requested for
additional data for its muscle-wasting treatment as the agency
decides whether to approve the...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment